Glaukos Corp. Company Profile (NYSE:GKOS)

About Glaukos Corp.

Glaukos Corp. logoGlaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring approximately one millimeter long and approximately 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a corneal incision. The Company's micro-scale injectable therapies include pipeline products, such as the iStent Inject, the iStent Supra and iDose. The iStent Inject includes approximately two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: GKOS
  • CUSIP:
Key Metrics:
  • Previous Close: $39.15
  • 50 Day Moving Average: $32.98
  • 200 Day Moving Average: $26.34
  • 52-Week Range: $33,024,000.00 - $14.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 170.22
  • P/E Growth: 0.00
  • Market Cap: $1.29B
  • Outstanding Shares: 33,024,000
  • Beta: 1.39
Profitability:
  • Net Margins: -1.23%
  • Return on Equity: -1.14%
  • Return on Assets: -0.94%
Debt:
  • Current Ratio: 6.01%
  • Quick Ratio: 5.72%
Additional Links:
Companies Related to Glaukos Corp.:

Analyst Ratings

Consensus Ratings for Glaukos Corp. (NYSE:GKOS) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $38.00 (2.94% downside)

Analysts' Ratings History for Glaukos Corp. (NYSE:GKOS)
Show:
DateFirmActionRatingPrice TargetDetails
9/25/2016Cantor FitzgeraldReiterated RatingBuy$41.00View Rating Details
8/2/2016Roth CapitalBoost Price TargetBuy$36.50 -> $41.00View Rating Details
8/2/2016Piper Jaffray Cos.Boost Price Target$42.00View Rating Details
4/8/2016Stifel NicolausInitiated CoverageHoldView Rating Details
3/2/2016JPMorgan Chase & Co.Lower Price TargetOverweight$32.00 -> $28.00View Rating Details
11/19/2015William BlairReiterated RatingOutperformView Rating Details
8/27/2015Goldman Sachs Group Inc.Lower Price Target$33.00 -> $32.00View Rating Details
7/20/2015Bank of America Corp.Initiated CoverageBuy$37.00View Rating Details
7/20/2015Canaccord GenuityInitiated CoverageBuy$35.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Glaukos Corp. (NYSE:GKOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/1/2016Q216($0.04)$0.06$24.45 million$28.60 millionViewN/AView Earnings Details
5/3/2016Q116($0.15)$0.03$18.77 million$23.10 millionViewN/AView Earnings Details
3/1/2016Q415($0.13)($0.07)$20.07 million$20.28 millionViewN/AView Earnings Details
11/10/2015Q315($0.17)($0.07)$17.93 million$19.00 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Glaukos Corp. (NYSE:GKOS)
Current Year EPS Consensus Estimate: $0.10 EPS
Next Year EPS Consensus Estimate: $0.23 EPS

Dividends

Dividend History for Glaukos Corp. (NYSE:GKOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Glaukos Corp. (NYSE:GKOS)
Insider Ownership Percentage: 36.80%
Institutional Ownership Percentage: 71.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/12/2016Jonathan SilversteinDirectorSell292,938$33.69$9,869,081.22View SEC Filing  
8/3/2016Orbimed Advisors LlcDirectorSell425,000$30.59$13,000,750.00View SEC Filing  
7/27/2016Richard L HarrisonCFOSell10,000$35.01$350,100.00View SEC Filing  
7/13/2016Thomas William BurnsCEOSell162,254$30.07$4,878,977.78View SEC Filing  
7/12/2016Richard L HarrisonCFOSell5,700$30.00$171,000.00View SEC Filing  
6/20/2016Richard L HarrisonCFOSell4,300$30.00$129,000.00View SEC Filing  
6/20/2016Thomas William BurnsCEOSell7,997$30.00$239,910.00View SEC Filing  
6/15/2016Chris M CalcaterraInsiderSell45,464$28.46$1,293,905.44View SEC Filing  
6/6/2016Thomas William BurnsCEOSell24,578$25.16$618,382.48View SEC Filing  
6/3/2016Thomas William BurnsCEOSell422$25.00$10,550.00View SEC Filing  
6/1/2016Thomas William BurnsCEOSell25,000$23.90$597,500.00View SEC Filing  
5/25/2016Thomas William BurnsCEOSell300$25.00$7,500.00View SEC Filing  
5/4/2016Chris M CalcaterraInsiderSell74,536$24.40$1,818,678.40View SEC Filing  
5/4/2016Richard L HarrisonCFOSell30,000$24.59$737,700.00View SEC Filing  
5/4/2016Thomas William BurnsCEOSell36,700$24.67$905,389.00View SEC Filing  
3/4/2016Aimee S WeisnerDirectorBuy2,500$16.03$40,075.00View SEC Filing  
2/25/2016Montreux Equity Partners Iv LpMajor ShareholderSell70,000$16.16$1,131,200.00View SEC Filing  
12/31/2015Richard L HarrisonCFOBuy1,388$15.30$21,236.40View SEC Filing  
11/12/2015Aimee S WeisnerDirectorBuy2,500$21.83$54,575.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Glaukos Corp. (NYSE:GKOS)
DateHeadline
streetinsider.com logoGlaukos Corporation (GKOS): Durable Efficacy Data in iStent Study - Cantor (NYSE:GKOS)
www.streetinsider.com - September 24 at 4:55 PM
streetinsider.com logoGlaukos Corporation (GKOS): Durable Efficacy Data in iStent Study - Cantor - StreetInsider.com (NYSE:GKOS)
www.streetinsider.com - September 23 at 4:55 PM
News IconUpcoming Earnings Report: Glaukos Corporation (NYSE:GKOS) - The Voice Registrar (NYSE:GKOS)
voiceregistrar.com - September 23 at 10:12 AM
News IconWhat is the Street Saying About Glaukos Corp (NYSE:GKOS)? - Frisco Fastball (NYSE:GKOS)
friscofastball.com - September 22 at 5:18 PM
stocksdaily.net logoGlaukos Corp (NYSE:GKOS) Ratings in Focus - Stocks Daily (NYSE:GKOS)
www.stocksdaily.net - September 22 at 5:18 PM
publicnow.com logoInternational Study Shows Favorable 3-Year Results of 2 Glaukos iStent® Trabecular Micro-Bypass Stents as Initial Treatment for Naïve Glaucoma (NYSE:GKOS)
www.publicnow.com - September 22 at 5:18 PM
stocksdaily.net logoGlaukos Corp (NYSE:GKOS) Ratings in Focus (NYSE:GKOS)
www.stocksdaily.net - September 21 at 5:43 PM
News IconGlaukos Corp (GKOS) CEO Sells $618382.48 in Stock - DailyQuint (NYSE:GKOS)
dailyquint.com - September 21 at 5:43 PM
marketwatch.com logoDamage done to stocks means investors need to hit ‘pause’ (NYSE:GKOS)
www.marketwatch.com - September 17 at 9:54 AM
finance.yahoo.com logoGlaukos Hits a 52-Week High on Positive Estimate Revisions (NYSE:GKOS)
finance.yahoo.com - September 16 at 5:05 PM
investors.com logoStocks Fall But Nasdaq Up 2% For The Week; Apple, Glaukos Finish Strong (NYSE:GKOS)
www.investors.com - September 16 at 5:05 PM
fidaily.com logoGlaukos Corporation Common Stoc (GKOS) Reaches New 52-Week High - Finance Daily (NYSE:GKOS)
www.fidaily.com - September 15 at 5:37 PM
marketwatch.com logoDamage done to stocks means investors need to hit 'pause' - MarketWatch (NYSE:GKOS)
www.marketwatch.com - September 15 at 5:37 PM
capitalcube.com logoETF’s with exposure to Glaukos Corp. : September 14, 2016 (NYSE:GKOS)
www.capitalcube.com - September 14 at 5:19 PM
capitalcube.com logoETF’s with exposure to Glaukos Corp. : September 14, 2016 (NYSE:GKOS)
www.capitalcube.com - September 14 at 5:19 PM
investors.com logoTo Beat Glaucoma, This Company Thrives By Putting A Stick In Your Eye (NYSE:GKOS)
www.investors.com - September 9 at 5:02 PM
capitalcube.com logoGlaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : September 9, 2016 (NYSE:GKOS)
www.capitalcube.com - September 9 at 9:59 AM
investors.com logoEye Surgery Or Drops? Glaukos Is Persuading People To Take Option 1 (NYSE:GKOS)
www.investors.com - September 9 at 9:59 AM
News IconPlacing Glaukos Corp (NYSE:GKOS) Shares Under the Microscope - Post News (NYSE:GKOS)
www.kentuckypostnews.com - September 8 at 9:03 AM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Glaukos Corp (NYSE:GKOS) Stock - Frisco Fastball (NYSE:GKOS)
friscofastball.com - September 8 at 9:03 AM
News IconUpcoming Earnings Report: Glaukos Corporation (NYSE:GKOS ... - The Voice Registrar (NYSE:GKOS)
voiceregistrar.com - September 8 at 9:03 AM
publicnow.com logoMultiple Surgeons to Present Clinical Data Regarding Glaukos Glaucoma Devices at 2016 European Society of Cataract and Refractive Surgeons Congress (NYSE:GKOS)
www.publicnow.com - September 6 at 9:58 AM
finance.yahoo.com logoGlaukos Announces Participation in Baird Healthcare Conference (NYSE:GKOS)
finance.yahoo.com - August 24 at 5:06 PM
capitalcube.com logoETF’s with exposure to Glaukos Corp. : August 23, 2016 (NYSE:GKOS)
www.capitalcube.com - August 23 at 5:23 PM
capitalcube.com logoGlaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : August 22, 2016 (NYSE:GKOS)
www.capitalcube.com - August 22 at 9:52 AM
4-traders.com logoGlaukos : $15 Target Price If More Insurers Change Reimbursements (NYSE:GKOS)
www.4-traders.com - August 21 at 9:38 AM
seekingalpha.com logoGlaukos: $15 Target Price If More Insurers Change Reimbursements (NYSE:GKOS)
seekingalpha.com - August 20 at 9:27 AM
fidaily.com logoGlaukos Corporation Common Stoc (NYSE:GKOS) Trading Up – Insiders Selling, Short Interest Growing (NYSE:GKOS)
www.fidaily.com - August 13 at 8:08 AM
finance.yahoo.com logoGLAUKOS CORP Financials (NYSE:GKOS)
finance.yahoo.com - August 12 at 5:16 PM
live-pr.com logoGlaukos Corporation (GKOS) - Medical Equipment - Deals and Alliances Profile - New Report Available (NYSE:GKOS)
www.live-pr.com - August 11 at 5:26 PM
capitalcube.com logoETF’s with exposure to Glaukos Corp. : August 11, 2016 (NYSE:GKOS)
www.capitalcube.com - August 11 at 5:26 PM
seekingalpha.com logoIstar Flies Towards Next-Gen Glaucoma Surgery Device (NYSE:GKOS)
seekingalpha.com - August 9 at 4:00 PM
capitalcube.com logoGlaukos Corp. :GKOS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NYSE:GKOS)
www.capitalcube.com - August 9 at 4:00 PM
tradecalls.org logoGilder Gagnon Howe Co buys $37566536 stake in Glaukos Corp (GKOS) - Trade Calls (NYSE:GKOS)
www.tradecalls.org - August 5 at 5:21 PM
News IconTraders Recap: TD Ameritrade Holding Corp.(NASDAQ:AMTD), Glaukos Corp(NYSE:GKOS) - NYSE Journal (press release) (NYSE:GKOS)
stockznews.com - August 4 at 8:09 AM
tradecalls.org logoAnalyst Rating Update on Glaukos Corporation (GKOS) - Trade Calls (NYSE:GKOS)
www.tradecalls.org - August 4 at 8:09 AM
News IconGlaukos raises guidance after Street-beating Q2 (NYSE:GKOS)
www.massdevice.com - August 2 at 5:29 PM
breakingfinancenews.com logoRoth Capital announced (NYSE:GKOS) Glaukos Corporation, bumping up its price target to $41 earlier today (NYSE:GKOS)
breakingfinancenews.com - August 2 at 5:29 PM
finance.yahoo.com logoEdited Transcript of GKOS earnings conference call or presentation 1-Aug-16 8:30pm GMT (NYSE:GKOS)
finance.yahoo.com - August 2 at 10:02 AM
sg.finance.yahoo.com logoGlaukos beats 2Q profit forecasts (NYSE:GKOS)
sg.finance.yahoo.com - August 1 at 5:08 PM
publicnow.com logoGlaukos Corporation Announces Second Quarter 2016 Financial Results (NYSE:GKOS)
www.publicnow.com - August 1 at 5:08 PM
biz.yahoo.com logoQ2 2016 Glaukos Corp Earnings Release - After Market Close (NYSE:GKOS)
biz.yahoo.com - August 1 at 7:07 AM
News IconHow Analysts Feel About Glaukos Corp (NYSE:GKOS)? - Consumer Eagle (NYSE:GKOS)
www.consumereagle.com - July 22 at 5:08 PM
News IconGlaukos Corp Just Reaches 52-Week High? - Consumer Eagle (NYSE:GKOS)
www.consumereagle.com - July 22 at 8:06 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Glaukos Corp (NYSE:GKOS) - TGP (NYSE:GKOS)
telanaganapress.com - July 21 at 8:47 AM
News IconStock Touching Overbought Territory: Glaukos Corporation (NYSE:GKOS) - Press Telegraph (NYSE:GKOS)
presstelegraph.com - July 20 at 6:37 PM
News IconEquity Roundup: Stock Performance Focus on Glaukos Corp (NYSE:GKOS) - Press Telegraph (NYSE:GKOS)
presstelegraph.com - July 20 at 8:05 AM
News IconGlaukos Corp (NYSE:GKOS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NYSE:GKOS)
www.engelwooddaily.com - July 20 at 8:05 AM
finance.yahoo.com logoGlaukos Corporation to Release Second Quarter 2016 Financial Results after Market Close on August 1 (NYSE:GKOS)
finance.yahoo.com - July 18 at 4:30 PM
News IconStock in Positive Territory for the Quarter: Glaukos Corporation (NYSE:GKOS) - Engelwood Daily (NYSE:GKOS)
www.engelwooddaily.com - July 18 at 10:24 AM

Social

Glaukos Corp. (NYSE:GKOS) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff